生物活性 | |||
---|---|---|---|
描述 | Flumatinib mesylate (HH-GV-678) is an oral, selective inhibitor of Bcr-Abl, inhibiting c-Abl, PDGFRβ, and c-Kit with IC50 values of 1.2, 307.6, and 665.5 nM, respectively. It inhibits Bcr-Abl autophosphorylation and phosphorylation of Stat5 and Erk1/2, impeding tumor growth in a chronic myelogenous leukemia model [1][2]. |
实验方案 | |||
---|---|---|---|
1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
1.52mL 0.30mL 0.15mL |
7.59mL 1.52mL 0.76mL |
15.18mL 3.04mL 1.52mL |
参考文献 |
---|